QUICK LINKS
Central cannabinoid receptor antagonists may have potential in the treatment of a number of diseases such as neuro-inflammatory disorders, cognitive disorders, septic shock, obesity, psychosis, addiction, and gastrointestinal disorders.1 (S)-SLV 319 is a strong and selective CB1 receptor antagonist with Ki values of 7.8 and 7,943 nM for CB1 and CB2, respectively.1 (S)-SLV 319 is less lipophilic and therefore more water soluble than other known CB1 receptor ligands.2
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
(S)-SLV 319, 1 mg | sc-222285 | 1 mg | $92.00 | |||
(S)-SLV 319, 5 mg | sc-222285A | 5 mg | $311.00 |